We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Patterson Cos. (PDCO) Rises As Market Takes a Dip: Key Facts
Read MoreHide Full Article
The latest trading session saw Patterson Cos. (PDCO - Free Report) ending at $29.09, denoting a +1.43% adjustment from its last day's close. The stock's change was more than the S&P 500's daily loss of 0.1%. Meanwhile, the Dow experienced a rise of 0.33%, and the technology-dominated Nasdaq saw a decrease of 0.3%.
Prior to today's trading, shares of the medical supplies maker had lost 3.21% over the past month. This has lagged the Medical sector's gain of 2.32% and the S&P 500's gain of 5.78% in that time.
The upcoming earnings release of Patterson Cos. will be of great interest to investors. The company's earnings per share (EPS) are projected to be $0.60, reflecting a 3.23% decrease from the same quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $1.63 billion, up 2% from the prior-year quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $2.38 per share and a revenue of $6.62 billion, representing changes of -1.65% and +2.31%, respectively, from the prior year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Patterson Cos. Such recent modifications usually signify the changing landscape of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.05% decrease. Patterson Cos. presently features a Zacks Rank of #4 (Sell).
Looking at its valuation, Patterson Cos. is holding a Forward P/E ratio of 12.07. This expresses a discount compared to the average Forward P/E of 18.85 of its industry.
It is also worth noting that PDCO currently has a PEG ratio of 1.44. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Medical - Dental Supplies industry currently had an average PEG ratio of 2.04 as of yesterday's close.
The Medical - Dental Supplies industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 97, finds itself in the top 39% echelons of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Patterson Cos. (PDCO) Rises As Market Takes a Dip: Key Facts
The latest trading session saw Patterson Cos. (PDCO - Free Report) ending at $29.09, denoting a +1.43% adjustment from its last day's close. The stock's change was more than the S&P 500's daily loss of 0.1%. Meanwhile, the Dow experienced a rise of 0.33%, and the technology-dominated Nasdaq saw a decrease of 0.3%.
Prior to today's trading, shares of the medical supplies maker had lost 3.21% over the past month. This has lagged the Medical sector's gain of 2.32% and the S&P 500's gain of 5.78% in that time.
The upcoming earnings release of Patterson Cos. will be of great interest to investors. The company's earnings per share (EPS) are projected to be $0.60, reflecting a 3.23% decrease from the same quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $1.63 billion, up 2% from the prior-year quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $2.38 per share and a revenue of $6.62 billion, representing changes of -1.65% and +2.31%, respectively, from the prior year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Patterson Cos. Such recent modifications usually signify the changing landscape of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.05% decrease. Patterson Cos. presently features a Zacks Rank of #4 (Sell).
Looking at its valuation, Patterson Cos. is holding a Forward P/E ratio of 12.07. This expresses a discount compared to the average Forward P/E of 18.85 of its industry.
It is also worth noting that PDCO currently has a PEG ratio of 1.44. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Medical - Dental Supplies industry currently had an average PEG ratio of 2.04 as of yesterday's close.
The Medical - Dental Supplies industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 97, finds itself in the top 39% echelons of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.